Tang, M. T., Keir, M. E., Erickson, R., Stefanich, E. G., Fuh, F. K., Ramirez‐Montagut, T., . . . Danilenko, D. M. (2018). Review article: Nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease. Aliment Pharmacol Ther.
Stile di citazione ChicagoTang, M. T., M. E. Keir, R. Erickson, E. G. Stefanich, F. K. Fuh, T. Ramirez‐Montagut, J. M. McBride, e D. M. Danilenko. "Review Article: Nonclinical and Clinical Pharmacology, Pharmacokinetics and Pharmacodynamics of Etrolizumab, an Anti‐β7 Integrin Therapy for Inflammatory Bowel Disease." Aliment Pharmacol Ther 2018.
Citazione MLATang, M. T., et al. "Review Article: Nonclinical and Clinical Pharmacology, Pharmacokinetics and Pharmacodynamics of Etrolizumab, an Anti‐β7 Integrin Therapy for Inflammatory Bowel Disease." Aliment Pharmacol Ther 2018.